Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : BORL: Time to BUY! -- Ignore unavailable to you. Want to Upgrade?

To: John Solder who wrote (7634)	11/21/1997 10:01:00 AM
From: Neil Booth	Respond to of 10836

My question is which number is fixed, the sale price of $150MM or the 0.89188 conversion ratio at transaction date. Which do you think? <g> Which number just rolls off your tongue, and which one wouldn't you think of in a million years? Neil.

To: John Solder who wrote (7634)	11/21/1997 11:52:00 AM
From: Sam Scrutchins	Read Replies (1) \| Respond to of 10836

John, What can you tell us about each of these licensing agreements that Visigenic has with companies like Oracle and Sun, etc. What does it mean in terms of revenue and potential bottom line. If a license agreement is signed with another company for the same product, is this clear profit after sales and overhead costs, or is some portion of product development costs somehow allocated to the new agreement. One way or another, how much is each new licensing agreement worth? I apologize for the wording of these questions. Once I understand the process a little more, I can be more specific. In any event, your assistance is appreciated. TIA. Sam